You are here: Home » Companies » News
Business Standard

Zydus gets audit report of Ahmedabad-based SEZ plant from USFDA

Inspection was conducted during January in 2017

Press Trust of India  |  New Delhi 

Zydus gets audit report of Ahmedabad-based SEZ plant from USFDA

Drug firm Cadila on Tuesday said it has received establishment inspection report from the for its manufacturing facility at Pharma at

The plant had completed the United States Food and Drug Administration (USFDA) from January 16-24, 2017, Cadila said in a statement.

The company's "formulations manufacturing facility at Pharma SEZ, has received an Establishment Inspection Report (EIR) from the signifying the successful closure of the audit", it added.

of Cadila Healthcare, the listed entity of Group were on Tuesday trading at Rs 499.75 per scrip in the afternoon trade on BSE, down 0.26 per cent from the previous close.

First Published: Tue, August 29 2017. 14:36 IST
RECOMMENDED FOR YOU